Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Anesthesiology
Published in: BMC Anesthesiology 1/2017

Open Access 01-12-2017 | Case report

Perioperative management of paraganglioma and catecholamine-induced cardiomyopathy in child– a case report and review of the literature

Authors: Xixi Jia, Xiangyang Guo, Qing Zheng

Published in: BMC Anesthesiology | Issue 1/2017

Login to get access

Abstract

Background

Paragangliomas are catecholamine-secreting tumors of the paraganglia. Perioperative mortality of children with paraganglioma is high, but preoperative therapy and anesthetic management of paraganglioma resection are controversial in children. The literatures on catecholamine-induced cardiomyopathy are limited to several case reports,with few reports of studies on children.

Case presentation

Here we report the anesthetic management of a child with paraganglioma and catecholamine-induced cardiomyopathy, and the possible perioperative anesthesia problems of the paraganglioma resection are discussed.

Conclusion

Preoperative and intraoperative anesthetic management of Pheochromocytomas children should follow the same principles as for adults, The most important aspects are the control of blood pressure liability and maintenance of adequate blood volume. Pheochromocytomas patient may have cardiomoyopathy due to myocardial toxicity of excessive circulating catecholamines level. The perioperative management of catecholamine-induced cardiomyopathy should include lowering sympathetic activation by means of α-and β-adrenergic receptor blocker and diuretics administration in case of volume overload.
Literature
1.
Renard J, Clerici T, Licker M, et al. Pheochromocytoma and abdominal paraganglioma. J Visc Surg. 2011;148:409–16.CrossRef
2.
Guerrero MA, Schreinemakers JM, Vriens MR, Suh I, Hwang J, Shen WT, Gosnell J, Clark OH, Duh QY. Clinical spectrum of pheochromocytoma. Journal of the American College of Surgeons. 2009;209:727–32.CrossRefPubMed
3.
Kopetschke R, Slisko M, Kilisli A, Tuschy U, Wallaschofski H, Fassnacht M, Ventz M, Beuschlein F, Reincke M, Reisch N, Quinkler M. Frequent incidental discovery of phaeochromocytoma:data from a German cohort of 201 phaeochromocytoma.European. Journal of Endocrinology. 2009;161:355–61.
4.
5.
Naranjo J, Dodd S, Martin YN. Perioperative Management of Pheochromocytoma. J Cardiothorac Vasc Anesth. 2017;31(4):1427–39.CrossRefPubMed
6.
Prejbisz A, Lenders JWM, Eisenhofer G. Et al.Cardiovascular manifestations of phaeochromocytoma. J Hypertens. 2011;29:2049–60.CrossRefPubMed
7.
Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab. 2007;92:4069–79.CrossRefPubMed
8.
McMillian WD,Trombley BJ,Charash WE&Christian RC.Phentolamine continuous infusion in a patient with pheochromocytoma.Am J Health Syst Pharm 2011;68:130–134.
9.
Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:1915–42.CrossRefPubMed
10.
Lentschener C, Gaujoux S, Thillois JM, Duboc D, Bertherat J, Ozier Y, Dousset B. Increased arterial pressure is not predictive of haemodynamic instability in patients undergoing adrenalectomy for phaeochromocytoma. Acta Anaesthesiologica Scandinavlca. 2009;53:522–7.CrossRef
11.
Ulchaker JC, Goldfarb DA, Bravo EL, Novick AC. Successful outcomes in pheochromocytoma surgery in the modern era. Journal of Urology. 1999;161:764–7.CrossRefPubMed
12.
Bruynzeel H, Feelders RA, Groenland TH, van den Meiracker AH, van Eijck CH, Lange JF, de Herder WW, Kazemier G. Risk factors for hemodynamic instability during surgery for pheochromocytoma. Journal of Clinical Endocrinology and Metabolism. 2010;95:678–85.CrossRefPubMed
13.
Brierley J, Carcillo JA, Choong K, et al. Clinical practice septic shock :2007 update from the American College of Clinical Care Medicine. Crit Care Med. 2009;37:666–88.CrossRefPubMedPubMedCentral
14.
Slagt C, Malagon I, Groeneveld AB. Systematic review of uncalibrated arterial pressure waveform analysis to determine cardiac output and stroke volume variation. Br J Anaesth. 2014 Apr;112(4):626–37.CrossRefPubMed
15.
Gan H, Cannesson M, Chandler JR, et al. Predicting fluid responsiveness in children: a systematic review. Anesth Analg. 2013;117:1380–92.CrossRefPubMed
16.
Tadokoro T, Kakinohana M, Fukumoto C, et al. Usefulness of stroke volume variation to assess blood volume during blood removal for autologous blood transfusion in pediatric patients. Pediatric Anaesth. 2016 Mar;26(3):300–6.CrossRef
17.
Teng S, Kaufman J, Pan Z, et al. Continuous arterial pressure waveform monitoring in pediatric cardiac transplant, cardiomyopathy and pulmonary hypertension patients. Intensive Care Med. 2011;37(8):1297–301.CrossRefPubMed
18.
Byon HJ, Lim CW, Lee JH, et al. Prediction of fluid responsiveness in mechanically ventilated children undergoing neurosurgery. Br J Anaesth. 2013;110:586–91.CrossRefPubMed
19.
Lentschener C, Gaujoux S, Tesniere A, Dousset B. Point of controversy:perioperative care of patients undergoing pheochromocytoma removal-time for a reappraisal?European Jounal of. Endocrinology. 2011;165:365–73.
20.
Grasselli G, Foti G, Patroniti N, Rona R, Periangeli MV, Pesenti A. Extracorporeal cardiopulmonary support for cardiogenic shock caused by pheochromocytoma:a case report and literature review. Anesthesiology. 2008;108:959–62.CrossRefPubMed
21.
Wu GY, Doshi AA, Haas GJ. Pheochromocytoma induced cardiogenic shock with rapid recovery of ventricular function. Eur J Heart Fail. 2007;9:212–4.CrossRefPubMed
22.
Agarwal G, Sadacharan D, Kapoor A, Batra A, et al. Cardiovascular dysfunction and catecholamine cardiomyopathy in pheochromocytoma patients and their reversal following surgical cure:Results of a prospective case-control study. Surgery. 2011;150:1202–11.CrossRefPubMed
23.
Aleksander Prejbisz,Jacques W.M.Lenders,Graeme Eisenhofer,Andrzej Januszewicz .Cardiovascular manifestations of phaeochromocytoma.Journal of Hypertension 2011,29:2049–2060.
24.
Kim J, Reutrakul S, Davis DB, Kaplan EL, Refetoff S. Multiple endocrine neoplasa 2A syndrome presenting as peripartum cardiomyopathy due to catecholamine excess. Eur J Endocrinol. 2004;151:771–7.CrossRefPubMed
25.
Takizawa M, Kobayakawa N, Uozumi H, Yonemura S, Kodama T, Fukusima K, Takeuchi H, Kaneko Y, Kaneko T, Fujita K, Honma Y, Aoyagi T. A case of transient left ventricular ballooning with pheochromocytoma,supporting pathogenetic role of catecholamines in stress-induced cardiomyopathy or takotsubo cardiomyopathy. Int J Cardiol. 2007;114:15–7.CrossRef
26.
Jindal V, Baker ML, Aryangat A, Wittlin SD, Bisognano JD, Richter HS. Pheochromocytoma: presenting with regular cyclic blood pressure and inverted Takotsubo cardiomyopathy. J Clin Hypertens. 2009;11:81–6.CrossRef
27.
Lassnig E, Weber T, Auer J, Nomeyer R, Eber B. Pheochromocytoma crisis presenting with shock and tako-tsubo-like cardiomyopathy. Int J Cardiol. 2009;134:138–40.CrossRef
28.
Zielen P, Klisiewicz A, Januszewicz A, Prejbisz A, Kabat M, Peczkowska M, et al. Pheochromocytoma-related ‘classic’ takotsubo cardiomyopathy. J Hum Hypertens. 2010;24:363–6.CrossRefPubMed
29.
Galiuto L, De Caterina AR, Porfidia A, Paraggio L, Barchetta S, Locorotondo G, et al. Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in apical ballooning or Tako-Tsubo syndrome. Eur Heart J. 2010;31:1319–27.CrossRefPubMed
30.
Eugene A, Hessel MD II. Takotsubo cardiomyopathy and its relevance to anesthesiology: a narrative review. J Can Anesth. 2016;63:1059–74.CrossRef
31.
Wester T, Franklin A, Donahue BS. Perioperative Management of a Pediatric Patient with catecholamine-induced cardiomyopathy undergoing laparoscopic Paraganglioma excision requiring biventricular assist device support. J Cardio thorac Vasc Anesth. 2015;29(4):999–1002.CrossRef
32.
De Miguel V, Arias A, Paissan A, et al. Catecholamine-induced myocarditis in pheochromocytoma. Circulation. 2014;129:1348–9.CrossRefPubMed
Metadata
Title
Perioperative management of paraganglioma and catecholamine-induced cardiomyopathy in child– a case report and review of the literature
Authors
Xixi Jia
Xiangyang Guo
Qing Zheng
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Anesthesiology / Issue 1/2017
Electronic ISSN: 1471-2253
DOI
https://doi.org/10.1186/s12871-017-0433-0

Other articles of this Issue 1/2017

BMC Anesthesiology 1/2017 Go to the issue

Research article

Comparison of the trapezius and the adductor pollicis muscle as predictor of good intubating conditions: a randomized controlled trial

Research article

Tramadol vs dexmedetomidine for emergence agitation control in pediatric patients undergoing adenotonsillectomy with sevoflurane anesthesia: prospective randomized controlled clinical study

Research article

Effect of ultrasonography and fluoroscopic guidance on the incidence of complications of cannulation in extracorporeal cardiopulmonary resuscitation in out-of-hospital cardiac arrest: a retrospective observational study

Research article

Combination of gabapentin and ramosetron for the prevention of postoperative nausea and vomiting after gynecologic laparoscopic surgery: a prospective randomized comparative study

Research article

Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy

Research article

Effects of dexmedetomidine on TNF-α and interleukin-2 in serum of rats with severe craniocerebral injury